Keywords: Santaris Pharma, Pfizer, Wyeth, mRNA, microRNA targeted drugs

Denmark’s Santaris could earn over $600 million in expanded deal with Pfizer

Article | 05 January 2011

Global drugs behemoth Pfizer (NYSE: PFE) has expanded its collaboration with Danish firm Santaris Pharma A/S, a clinical-stage biopharmaceutical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pfizer

Santaris Pharma

Wyeth

Go to company listing